• Hyperthermia and Cisplatin Synergy: Caspase-8 Drives Cancer

  2026-05-30

  This study uncovers a novel mechanism by which hyperthermia and cisplatin combination therapy enhances cancer cell apoptosis and pyroptosis through caspase-8 polyubiquitination and activation. By dissecting the interplay between caspase-8, p62, and downstream cell death pathways, the research provides a framework for optimizing combinatorial cancer therapies targeting regulated cell death.

• Annexin V-FITC/PI Apoptosis Assay Kit: Best Practices in Apo

  2026-05-29

  This article provides practical, scenario-driven guidance for biomedical researchers using the Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003). It addresses real-world laboratory challenges in apoptosis detection, grounded in validated protocols and recent literature, to help ensure reliable, reproducible quantitative data.

• Toremifene: Selective Estrogen-Receptor Modulator in Prostat

  2026-05-29

  Toremifene stands out as a second-generation selective estrogen-receptor modulator, enabling precision studies in prostate cancer biology—especially when probing hormone-dependent signaling and metastatic mechanisms. By integrating data-driven workflows, this article empowers researchers to optimize protocols and troubleshoot common challenges in advanced in vitro and in vivo models.

• Applied Workflows with (S)-1-(3-fluoro-4-(trifluoromethoxy)p

  2026-05-28

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) empowers translational researchers to dissect signaling pathways and enzyme inhibition with precision. This guide delivers actionable protocols, troubleshooting strategies, and practical insights drawn from recent mechanistic and workflow-focused studies.

• ATS-9R: Strategic Innovation in Adipocyte Gene Silencing

  2026-05-28

  ATS-9R (Adipocyte-targeting sequence-9-arginine) represents a paradigm shift in non-viral gene delivery for metabolic disease research. This article explores the mechanistic precision of Prohibitin-mediated endocytosis, strategic guidance for translational researchers, and the clinical relevance demonstrated in recent studies for targeting adipose tissue macrophages and mitigating insulin resistance.

• AICAR Phosphate (Acadesine): Advanced Insights for Mitochond

  2026-05-27

  Discover the advanced mechanisms of AICAR phosphate (Acadesine) as a potent AMPK activator and apoptosis inducer. This article uniquely explores its role in mitochondrial quality control and selective cancer cell apoptosis, offering deeper protocol guidance and new translational perspectives.

• Ellagic Acid: Selective CK2 Inhibition in Cancer Biology

  2026-05-27

  Ellagic acid is a highly selective, ATP-competitive inhibitor of casein kinase 2 (CK2), exhibiting potent activity in cancer biology research. Its unique specificity and biochemical properties make it a valuable tool for dissecting CK2-driven signaling and oxidative stress pathways. This article summarizes validated mechanisms, application protocols, and common misconceptions for experimental use.

• Cardiogreen (Indocyanine Green): Precision Workflows in Diag

  2026-05-26

  Cardiogreen (Indocyanine Green) empowers researchers to unify high-sensitivity vascular diagnostics with advanced apoptosis-inducing photodynamic therapy. This article unpacks proven experimental workflows, troubleshooting strategies, and the latest translational insights, setting a new standard for reproducibility and discovery.

• DiR (DiIC 18 (7)): Shaping the Future of EV Tracking & MPS E

  2026-05-26

  This thought-leadership article unpacks the mechanistic and strategic foundations of DiR (DiIC 18 (7)) as a transformative tool for advanced membrane imaging and extracellular vesicle (EV) tracking. Bridging insights from the latest 'Engage & Evasion' strategies, we guide translational researchers through optimizing MPS escape, maximizing in vivo imaging sensitivity, and setting new standards for regenerative medicine workflows. Distinguishing itself from conventional product-focused materials, this article integrates biological rationale, experimental design, and pragmatic protocol guidance—arming the scientific community with actionable intelligence.

• O-GlcNAcylation and Galectin-3 Regulation in Endoderm Differ

  2026-05-25

  This study provides a detailed analysis of how O-GlcNAcylation and galectin-3 secretion are dynamically regulated during differentiation of embryonic stem cells to extraembryonic endoderm. The findings clarify the non-essential role of global O-GlcNAc levels in lineage commitment, informing future approaches in stem cell and cancer signaling research.

• Annexin V-FITC/PI Apoptosis Assay Kit: Neurodegeneration Ins

  2026-05-25

  Explore how the Annexin V-FITC/PI Apoptosis Assay Kit advances early apoptosis detection in neurodegenerative research. This article uniquely bridges mechanistic innovation and practical assay optimization.

• CX-5461 in Cancer Biology: Ribosome Biogenesis Inhibition Re

  2026-05-24

  Explore how CX-5461, a potent RNA polymerase I inhibitor, is reshaping cancer research by targeting ribosome biogenesis and inducing cellular senescence and autophagy. This article offers unique insights into mechanistic advances and practical assay implications.

• Synthetic mRNA-Driven Differentiation of hiPSCs to Oligodend

  2026-05-23

  This study demonstrates a rapid, transgene-free protocol for differentiating human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes using a synthetic modified OLIG2 mRNA. The approach avoids genome integration, enhances translational efficiency, and offers a safer avenue for cell-based therapies in neurodegenerative diseases.

• Peroxiredoxin-Induced Autophagy in Entamoeba histolytica Inf

  2026-05-22

  This study uncovers how Entamoeba histolytica peroxiredoxin (Prx) activates autophagy in host macrophages via the TLR4-TRIF pathway, contributing to parasite-driven cell death. These findings reveal a novel pathogenic mechanism and provide new insights into host-pathogen interactions that may inform future therapeutic strategies.

• T0070907: Precision PPARγ Antagonist for Pathway Dissection

  2026-05-22

  T0070907, a nanomolar PPARγ antagonist from APExBIO, empowers researchers to dissect adipogenesis, inflammation, and cancer cell cycle dynamics with unparalleled specificity. This article translates recent mechanistic breakthroughs and experimental insights into actionable workflows and troubleshooting strategies for advanced cellular research.

16312 records 1/1088 page Next 12345 下5页 Last page